Expert Review of Clinical Immunology, Volume 18, Issue 3 (2022)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Clinical Immunology, Volume 18, Issue 3 (2022)

See all volumes and issues
Vol 20, 2024 Vol 19, 2023 Volume 18, 2022 Vol 17, 2021 Vol 16, 2020 Vol 15, 2019 Vol 14, 2018 Vol 13, 2017 Vol 12, 2016 Vol 11, 2015 Vol 10, 2014 Vol 9, 2013 Vol 8, 2012 Vol 7, 2011 Vol 6, 2010 Vol 5, 2009 Vol 4, 2008 Vol 3, 2007 Vol 2, 2006 Vol 1, 2005
Download citations Download PDFs Download issue

The JAKi in inflammatory disorders & arthritis: lights and shadows

Foreword

Editorial
JAK inhibitors: special issue foreword
James Galloway & Fabiola Atzeni
Pages: 179-180
Published online: 10 Mar 2022
CitationforJAK inhibitors: special issue foreword | Full Text | References | PDF (118.9 KB) | EPUB
  • 1484 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Editorial

Editorial
Do JAK inhibitors have a realistic future in treating Crohn’s disease?
Tommaso Lorenzo Parigi, Virginia Solitano, Laurent Peyrin-Biroulet & Silvio Danese
Pages: 181-183
Published online: 31 Dec 2021
First Page PreviewforDo JAK inhibitors have a realistic future in treating Crohn’s disease? | Full Text | References | PDF (139.5 KB) | EPUB
  • 4279 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Editorial
TYK2 inhibition: changing the treatment landscape for psoriasis?
Abrahim Abduelmula & Melinda J. Gooderham
Pages: 185-187
Published online: 23 Nov 2021
First Page PreviewforTYK2 inhibition: changing the treatment landscape for psoriasis? | Full Text | References | PDF (219.5 KB) | EPUB
  • 5216 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Editorial
How suitable are JAK inhibitors in treating the inflammatory component in patients with alopecia areata and vitiligo?
Emily C. Moya, Raquel L. Bruinsma, Katherine A. Kelly & Steven R. Feldman
Pages: 189-191
Published online: 06 Feb 2022
First Page PreviewforHow suitable are JAK inhibitors in treating the inflammatory component in patients with alopecia areata and vitiligo? | Full Text | References | PDF (907.5 KB) | EPUB
  • 2821 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Review

Patient-reported outcomes and realistic clinical endpoints for JAK inhibitors in rheumatoid arthritis
Vibeke Strand
Pages: 193-205
Published online: 15 Mar 2022
AbstractforPatient-reported outcomes and realistic clinical endpoints for JAK inhibitors in rheumatoid arthritis | Full Text | References | PDF (4 MB) | EPUB
  • 317 Views
  • 2 CrossRef citations
  • 0Altmetric
How effective are JAK-inhibitors? Perspectives from clinical trials and real-world studies
Kim Lauper & Kimme L. Hyrich
Pages: 207-220
Published online: 13 Oct 2021
AbstractforHow effective are JAK-inhibitors? Perspectives from clinical trials and real-world studies | Full Text | References | PDF (399.7 KB) | EPUB
  • 636 Views
  • 2 CrossRef citations
  • 0Altmetric
Evaluating topical JAK inhibitors as a treatment option for atopic dermatitis
Mohammad I. Fardos, Rohan Singh, Patrick O. Perche, Katherine A. Kelly & Steven R. Feldman
Pages: 221-231
Published online: 22 Oct 2021
AbstractforEvaluating topical JAK inhibitors as a treatment option for atopic dermatitis | Full Text | References | PDF (1.9 MB) | EPUB
  • 848 Views
  • 6 CrossRef citations
  • 0Altmetric
Safety of JAK inhibitors: focus on cardiovascular and thromboembolic events
Fabiola Atzeni, Călin D. Popa, Valeria Nucera & Michael T. Nurmohamed
Pages: 233-244
Published online: 17 Feb 2022
AbstractforSafety of JAK inhibitors: focus on cardiovascular and thromboembolic events | Full Text | References | PDF (716.1 KB) | EPUB
  • 1596 Views
  • 5 CrossRef citations
  • 0Altmetric
Article
Pathological relevance and treatment perspective of JAK targeting in systemic lupus erythematosus
Shingo Nakayamada & Yoshiya Tanaka
Pages: 245-252
Published online: 17 Feb 2022
AbstractforPathological relevance and treatment perspective of JAK targeting in systemic lupus erythematosus | Full Text | References | PDF (2 MB) | EPUB | Supplemental
  • 393 Views
  • 2 CrossRef citations
  • 0Altmetric
The infection risks of JAK inhibition
Maryam A. Adas, Edward Alveyn, Emma Cook, Mrinalini Dey, James B Galloway & Katie Bechman
Pages: 253-261
Published online: 29 Dec 2021
AbstractforThe infection risks of JAK inhibition | Full Text | References | PDF (1.9 MB) | EPUB
  • 3859 Views
  • 8 CrossRef citations
  • 0Altmetric
Open Access
Evaluating the use of JAK inhibitors in inflammatory connective tissue diseases in pediatric patients: an update
Jane Chuprin, Lindsay McCormack, Jillian M. Richmond & Mehdi Rashighi
Pages: 263-272
Published online: 04 Mar 2022
AbstractforEvaluating the use of JAK inhibitors in inflammatory connective tissue diseases in pediatric patients: an update | Full Text | References | PDF (3.9 MB) | EPUB
  • 418 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Tofacitinib for the treatment of active ankylosing spondylitis in adults
Raagav Mohanakrishnan, Secia Beier & Atul Deodhar
Pages: 273-280
Published online: 21 Feb 2022
AbstractforTofacitinib for the treatment of active ankylosing spondylitis in adults | Full Text | References | PDF (2 MB) | EPUB
  • 893 Views
  • 7 CrossRef citations
  • 0Altmetric
Comparing available JAK inhibitors for treating patients with psoriasis
Parker J. Funk, Patrick O. Perche, Rohan Singh, Katherine A. Kelly & Steven R. Feldman
Pages: 281-294
Published online: 10 Feb 2022
AbstractforComparing available JAK inhibitors for treating patients with psoriasis | Full Text | References | PDF (1.7 MB) | EPUB
  • 500 Views
  • 6 CrossRef citations
  • 0Altmetric
Recent issues in JAK inhibitor safety: perspective for the clinician
Roy Fleischmann
Pages: 295-307
Published online: 10 Feb 2022
AbstractforRecent issues in JAK inhibitor safety: perspective for the clinician | Full Text | References | PDF (379 KB) | EPUB
  • 742 Views
  • 4 CrossRef citations
  • 0Altmetric
Affecting the effectors: JAK inhibitors modulation of immune cell numbers and functions in patients with rheumatoid arthritis
Cristina Garufi, Mary Maclean, Massimo Gadina & Francesca Romana Spinelli
Pages: 309-319
Published online: 25 Feb 2022
AbstractforAffecting the effectors: JAK inhibitors modulation of immune cell numbers and functions in patients with rheumatoid arthritis | Full Text | References | PDF (469.5 KB) | EPUB
  • 1002 Views
  • 6 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Broadening the clinical spectrum of giant cell arteritis: from the classic cranial to the predominantly extracranial pattern of the disease
Miguel Ángel González-Gay et al.
Review Article | Published online: 17 May 2024
CSE1L as a prognostic biomarker associated with pan cancer immune infiltration and drug sensitivity
Haiyang Li et al.
Article | Published online: 16 May 2024
Updating on pregnancy in Rheumatoid Arthritis
Carlotta Schenone et al.
Review Article | Published online: 15 May 2024
Overcoming the challenges of primary resistance and relapse after CAR-T cell therapy
Alexandra Dreyzin et al.
Review Article | Published online: 14 May 2024
View all latest articles